News
A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs
28 Jan 2026
en
Join Crystal Bio's Co-founder, CTO, and Head of USA BD Ye Gu, Ph.D., as she presents at the Immuno-Oncology Summit 2024.
Title: Analytical Methods to Assess Critical Quality Attribute in mRNA-LNP Modality
Phase-appropriate strategies are pivotal to ensure the analyses to be adequate at each stage. Employing advanced analytical techniques such as high-resolution mass spectrometry, properly and timely, can address potential CMC issues to mitigate risks of delaying progress. This presentation will discuss the application of phase-appropriate strategies for analyses needed at each stage, and related examples such as developability and serum stability studies will be illustrated to highlight the application.
Date: August 19-22, 2024
Location: Sheraton Boston (39 Dalton Street)
Booth: T13
Ready for an evening of unscripted connection?
Please complete the form to register for our San Diego Biotech and Pharma R&D social. Note: Registration is subject to review. You will receive a formal confirmation email once your attendance is approved.
By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your registration. The information you submit will be governed by our Privacy Policy.
_.webp "A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs")
Subscribe to be the first to get the updates!
